Glytec Unveils the Next Evolution of GlucoMetricsⓇ, Giving Hospital Leaders New Insights and Analytics to Improve Glycemic Management and Readiness for New CMS Measures
“CMS is making it clear that hypoglycemia related to insulin is largely preventable, and early treatment and optimal management of severe hyperglycemia is a priority. But it’s hard to enact and measure this type of change without access to data, or the expertise to turn that data into actionable insights,” said Jordan Messler, MD, Chief Medical Officer at Glytec.